Therapeutic Potential of Roghan-e-Haft Barg (A Polyherbal Unani Formulation) with Special Reference to Musculoskeletal Disorders
Abstract
Background: Unani Medicine, an ancient medical system, focuses on both prevention and treatment of a variety of acute and chronic diseases. Its core therapeutic approaches include Ilāj bi’l Taghdhiya (diet therapy), Ilāj bi’l Tadbīr (regimenal therapy), Ilāj bi’l Dawā’ (pharmacotherapy), and Ilāj bi’l Yad (surgery). Within this framework, the term Waja‘ al-Mafāṣil broadly encompasses musculoskeletal disorders (MSDs), including inflammatory, non-inflammatory, infectious, and metabolic conditions. Pain is the most prevalent and primary symptom associated with MSDs. Musculoskeletal (MSK) pain remains a complex and difficult issue for both patients and healthcare providers. Nearly everyone experiences MSK pain at some point in their life, regardless of age, gender, or socioeconomic background. Statistics show that around 47% of the global population suffers from MSK pain, with approximately 39% to 45% requiring consistent medical intervention.
Objective: This review aims to comprehensively explore the phytopharmacology of the constituents of RHB and their pharmacological effects.
Materials and Methods: PubMed, Google Scholar, and Science Direct were used to collect data, which was then thoroughly evaluated.
Results: When chronic MSK pain is inadequately treated, it can significantly impair quality of life and contribute to substantial socioeconomic burdens. Roghan-e-Haft Barg (RHB), a recognized Unani formulation, has shown promising analgesic and anti-inflammatory properties when used topically.
Conclusion: Existing research suggests that the active components of RHB have significant pain-relieving and anti-inflammatory properties, making it a valuable therapeutic alternative for MSD management and improving patients' overall quality of life.
Keywords: Roghan-e-Haft Barg, Waja‘ al-Mafāṣil, Musculoskeletal disorders, Musculoskeletal pain
Keywords:
Roghan-e-Haft Barg, Waja‘ al-Mafāṣil, Musculoskeletal disorders, Musculoskeletal painDOI
https://doi.org/10.22270/jddt.v16i7.7864References
1. Chaudhari AJ, Raynor WY, Gholamrezanezhad A, Werner TJ, Rajapakse CS, Alavi A, Total-body PET imaging of musculoskeletal disorders, PET Clinics, 2021;16(1):99–117. DOI:10.1016/j.cpet.2020.09.012.
2. Tashani O, Johnson M, Avicenna's concept of pain, Libyan Journal of Medicine, 2010;5(1):5253. DOI:10.3402/ljm.v5i0.5253.
3. Ashraf R, Mohi-ud-din R, Unani aspect of arthritis (Waja ul Mafasil) and its management: A review, International Journal of Herbal Medicine, 2018; 6(3): 12–19.
4. World Health Organization. Musculoskeletal condition; 2019. Available at: https://www.who.int/news-room/factsheets/detail/musculoskeletal-conditions. Accessed March 20, 2026].
5. Smith E, Hoy DG, Cross M, Vos T, Naghavi M, Buchbinder R, The global burden of other musculoskeletal disorders: Estimates from the Global Burden of Disease 2010 study, Annals of the Rheumatic Diseases, 2014; 73(8):1462–1469. DOI:10.1136/annrheumdis-2013-204344.
6. Vos T, Abajobir AA, Abate KH, Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet, 2017; 390(10100):1211-1259. DOI:10.1016/S0140-6736(17)32154-2.
7. Cimmino MA, Ferrone C, Cutolo M, Epidemiology of chronic musculoskeletal pain, Best Practice and Research in Clinical Rheumatology, 2011; 25(2):173-183. DOI: 10.1016/j.berh.2010.01.012.
8. Babatunde OO, Jordan JL, van der Windt DA, Hill JC, Foster NE, Protheroe J, Effective treatment options for musculoskeletal pain in primary care: a systematic overview of current evidence, PLoS One, 2017;12(6):e0178621. DOI: 10.1371/journal.pone.0178621.
9. Qaseem A, Wilt TJ, McLean RM, Forciea MA; Clinical Guidelines Committee of the American College of Physicians, Noninvasive treatments for acute, sub acute, and chronic low back pain: a clinical practice guideline from the American College of Physicians, Annals of Internal Medicine, 2017;166(7):514-530. DOI: 10.7326/M16-2367.
10. Singh G, Ramey DR, NSAID-induced gastrointestinal complications: the ARAMIS perspective—1997, The Journal of Rheumatology and Supplements, 1998; 51:8-16.
11. Brun J, Jones R, Nonsteroidal anti-inflammatory drug–associated dyspepsia: the scale of the problem, The American Journal of Medicine, 2001;110(1):12-13. DOI: 10.1016/s0002-9343(00)00629-x.
12. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C, Do selective cyclo-oxygenase-2 inhibitors and traditional nonsteroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomized trials, British Medical Journal, 2006; 332(7553):1302-1308. DOI: 10.1136/bmj.332.7553.1302.
13. Vonkeman HE, Brouwers JR, Van de Laar MA, Understanding the NSAID-related risk of vascular events, British Medical Journal, 2006; 332(7546):895-898. DOI: 10.1136/bmj.332.7546.895.
14. Reynolds JF, Noakes TD, Schwellnus MP, Van der Windt A, Bowerbank P, Nonsteroidal antiinflammatory drugs fail to enhance healing of acute hamstring injuries treated with physiotherapy, South African Medical Journal, 1995; 85(6):517-522.
15. Sina I. Tarjuma wa Sharah Kulliyāt-i-Qanoon. Urdu translation by Kabiruddin. New Delhi, India: Aijaz Publishing House; 2006. P.238-239.
16. Nayab M, Islam M, An overview of Waja-ur-Rukbah (knee osteoarthritis) with reference to Waja-ul-Mafasil and its regimenal management (Ilaj bit Tadbeer) in Unani system of medicine, Asian Journal of Traditional, Complementary and Alternative Medicines, 2021;4(1-2):19-29. DOI:10.22040/ATCAM.2021.242486.1008.
17. Ansari A, Nayab M, Ansari A, Saleem S, An analytical review on ancient regimen: Dalk (massage) therapy in Unani system of medicine, International Journal of Research and Analytical Reviews, 2020;7(2):872-878.
18. Khan A. Al-Iksir. Vol 2. Urdu translation by H Kabiruddin. New Delhi, India: Idara Kitab-ul-Shifa; 2011.P.1439-1442.
19. Anonymous. National Formulary of Unani Medicine. Part 1. New Delhi, India: Department of AYUSH, Ministry of Health & Family Welfare, Government of India; 1993.P. 269.
20. Anonymous. National Formulary of Unani Medicine. Part 1. New Delhi, India: Central Council for Research in Unani Medicine, Department of AYUSH, Ministry of Health & Family Welfare, Government of India; 2006.P.194.
21. Anonymous. The Unani Pharmacopoeia of India. Part 1, Vol 1. New Delhi, India: Central Council for Research in Unani Medicine, Dept of AYUSH, Ministry of Health & Family Welfare, Government of India; 2007.P.3–4.
22. Kabiruddin H. Makhzan-ul-Mufradat. Lahore, Pakistan: Siddiqui Publication; n.d. P.49–52, 131–132, 198, 206–207, 288–289, 358, 370.
23. Hakeem A. Bustan-ul-Mufradat. New Delhi, India: Idara Kitab-ul-Shifa; 2002. P.63, 78–79, 131–132, 196–197, 202–203, 280, 343–344, 363.
24. Anonymous. Standardization of Single Drugs of Unani Medicine. Part 2. New Delhi, India: Central Council for Research in Unani Medicine; 1992.P.68–72.
25. Khan A. Muheet-e-Azam. Vol 1. New Delhi, India: Central Council for Research in Unani Medicine; 2012. P. 201–204, 703–705, 869–871.
26. Ghani N. Khazain-ul-Advia. New Delhi, India: Idara Kitab ul Shifa; n.d. P. 175–178, 218–220, 379–380, 701–704, 835–836, 875–876.
27. Obese E, Ameyaw EO, Biney RP, Henneh IT, Edzeamey FJ, Woode E, Phytochemical screening and anti-inflammatory properties of the hydroethanolic leaf extract of Calotropis procera (Ait.) R Br (Apocynaceae), Journal of Pharmaceutical Research International, 2018; 23(1):1–11.DOI: 10.9734/jpri/2018/42529.
28. Saba AB, Oguntoke PC, Oridupa O, Anti-inflammatory and analgesic activities of ethanolic leaf extract of Calotropis procera, African Journal of Biomedical Research, 2011;14(3):203–208. DOI:http://doi.org/10.4314/.
29. Anonymous. The Unani Pharmacopoeia of India. Part 1, Vol 3. New Delhi, India: Central Council for Research in Unani Medicine, Dept of AYUSH, Ministry of Health & Family Welfare, Government of India; 2007.P.8–9, 115–116.
30. Anonymous. Standardization of Single Drugs of Unani Medicine. Part 5. New Delhi, India: Central Council for Research in Unani Medicine; 2006.P.26–28.
31. Nabi MG. Makhzan-e-Mufradat wa Murakkabat. New Delhi, India: Central Council for Research in Unani Medicine, Ministry of Health and Family Welfare, Government of India; 2007.P.32, 37, 66, 96, 128, 147, 155.
32. Aoudia H, Oomah BD, Zaidi F, Yahiaoui R, Drover JCG, Harrison JE, Phenolics, antioxidant, and anti-inflammatory activities of Melia azedarach extracts, International Journal of Applied Research in Natural Products, 2013;6(2):19–29.
33. Vekariya S, Nishteswar K, Patel BR, Nariya M, Evaluation of analgesic and antipyretic activities of Mahanimba (Melia azedarach Linn.) leaf and root powder, An International Quarterly Journal of Research in Ayurveda, 2016;37(2):140–144. DOI: 10.4103/ayu.AYU 69 15.
34. Akacha M, Lahbib K, Boughanmi NG, Phytochemical evaluation and net antioxidant activity of Tunisian Melia azedarach leaves extract using ProAntidex parameter, Bangladesh Journal of Pharmacology, 2016;11(2):301–307. DOI: 10.3329/bjp.v11i2.25981.
35. Hossain MS, Saed A, Karmakar UK, et al. Assessment of phytochemical, analgesic, and antioxidant profile of Melia azedarach L leaves (family Meliaceae), The Pharma Innovation Journal, 2013;2(7):64–69.
36. Khare CP. Indian Medicinal Plants: An Illustrated Dictionary. Berlin/Heidelberg, Germany: Springer-Verlag; 2007. P.203–204, 551–552, 710–711, 764, 765, 767.
37. Taur DJ, Waghmare MG, Bandal RS, Patil RY, Antinociceptive activity of Ricinus communis L leaves, Asian Pacific Journal of Tropical Biomedicine, 2011;1(2):139–141. DOI: 10.1016/S2221-1691(11)60012-9.
38. Saini AK, Goyal R, Gauttam VK, Kalia AN, Evaluation of anti-inflammatory potential of Ricinus communis Linn leaves extracts and its flavonoids content in Wistar rats, Journal of Chemical and Pharmaceutical Research, 2010;2(5):690–695.
39. Hussain A, Aslam B, Muhammad F, et al. Anti-arthritic activity of Ricinus communis L and Withania somnifera L extracts in adjuvant-induced arthritic rats via modulating inflammatory mediators and subsiding oxidative stress, Iranian Journal of Basic Medical Sciences, 2021; 24(7):951–961. DOI: 10.22038/ijbms.2021.55145.12355.
40. Khan A. Muheet-e-Azam. Vol 2. New Delhi, India: Central Council for Research in Unani Medicine; 2013. P.611–612.
41. Aboluwodi AS, Avoseh ON, Lawal OA, Ogunwande IA, Giwa AA, Chemical constituents and anti-inflammatory activity of essential oils of Datura stramonium L, Journal of Medicinal Plants Studies, 2017;5(1):21–25.
42. Chandan G, Kumar C, Chibber P, et al. Evaluation of analgesic and anti-inflammatory activities and molecular docking analysis of steroidal lactones from Datura stramonium L, Phytomedicine, 2021;89: 153621. DOI: 10.1016/j.phymed.2021.153621.
43. Sonika G, Manubala R, Deepak J, Comparative studies on anti-inflammatory activity of Coriandrum sativum, Datura stramonium, and Azadirachta indica, Asian journal of Experimental Biological Sciences, 2010;1(1):151–159.
44. Anonymous. The Unani Pharmacopoeia of India. Part 1, Vol 5. New Delhi, India: Central Council for Research in Unani Medicine, Dept of AYUSH, Ministry of Health & Family Welfare, Government of India; 2008. P.78–79, 88–89.
45. Anonymous. Standardization of Single Drugs of Unani Medicine. Part 3. New Delhi, India: Central Council for Research in Unani Medicine; 1997. P.65–70.
46. Maniyar YA, Dasari S, Evaluation of anti-inflammatory activity of ethanolic extract of Vitex negundo flowers in experimental animals, Indian Journal of Pharmacy and Pharmacology, 2017; 4(4):172–175. DOI: 10.18231/2393-9087.2017.0037.
47. Dharmasiri MG, Jayakody JR, Galhena G, et al. Anti-inflammatory and analgesic activities of mature fresh leaves of Vitex negundo, Journal of Ethnopharmacology, 2003; 87(2–3):199–206. DOI: 10.1016/s0378-8741(03)00159-4.
48. Ahirrao RA, Patel MR, Anti-arthritic activity of Vitex negundo Linn. Leaves, Asian Journal of Research in Chemistry, 2012; 5(7):843–845.
49. Gupta RK, Tandon VR, Antinociceptive activity of Vitex negundo Linn. leaf extract, Indian Journal of Physiology and Pharmacology, 2005; 49(2):163–170.
50. Khan A. Muheet-e-Azam. Vol 3. New Delhi, India: Central Council for Research in Unani Medicine; 2014. P. 223–225.
51. Bhattacharya A, Agrawal D, Sahu P, Kumar S, Mishra S, Patnaik S, Analgesic effect of ethanolic leaf extract of Moringa oleifera on albino mice, Indian Journal of Pain, 2014; 28(2):89–94. DOI:10.4103/0970-5333.132846.
52. Caceres A, Saravia A, Rizzo S, Zabala L, De Leon E, Nave F, Pharmacologic properties of Moringa oleifera. II: Screening for antispasmodic, anti-inflammatory, and diuretic activity, Journal of Ethnopharmacology, 1992; 36(3):233–237. DOI: 10.1016/0378-8741(92)90049-w.
53. Mahajan SG, Mali RG, Mehta AA, Protective effect of ethanolic extract of seeds of Moringa oleifera Lam. against inflammation associated with development of arthritis in rats, Journal of Immunotoxicology, 2007; 4(1):39–47. DOI: 10.1080/15476910601115184.
54. Sultana A, Hossain MJ, Kuddus MR, Rashid MA, Zahan MS, Mitra S, et al. Ethnobotanical uses, phytochemistry, toxicology, and pharmacological properties of Euphorbia neriifolia Linn. against infectious diseases: a comprehensive review, Molecules, 2022;27(14):4374. DOI: 10.3390/molecules27144374.
55. Ilyas M, Parveen M, Muhaisen H, Basudan O, A novel triterpene (Neriifolione): a potent anti-inflammatory and antiarthritic agent from Euphorbia neriifolia, Hamdard Medicus, 2003;46 (2):97–102.
56. Gaur K, Rana AC, Nema RK, Kori ML, Sharma CS, Anti-inflammatory and analgesic activity of hydro-alcoholic leaves extract of Euphorbia neriifolia Linn, Asian Journal of Pharmaceutical and Clinical Research, 2009; 2(1):26–29.
57. Bigoniya P, Rana AC, Pharmacological screening of Euphorbia neriifolia leaf hydro-alcoholic extract, Journal of Applied Pharmacy, 2010;1(1):1–17. DOI:10.21065/19204159.2.1.
58. Anonymous. The Unani Pharmacopoeia of India. Part 1, Vol 2. New Delhi, India: Central Council for Research in Unani Medicine, Dept of AYUSH, Ministry of Health & Family Welfare, Government of India; 2007. P.71–72.
59. Monteiro EM, Chibli LA, Yamamoto CH, Pereira MC, Vilela FM, Rodarte MP, et al. Antinociceptive and anti-inflammatory activities of sesame oil and sesamin, Nutrients. 2014; 6(5):1931–1944. DOI: 10.3390/nu6051931.
60. Ruckmani A, Meti V, Vijayashree R, Arunkumar R, Konda VR, Prabhu L, et al. Anti-rheumatoid activity of ethanolic extract of Sesamum indicum seed extract in Freund’s complete adjuvant–induced arthritis in Wistar albino rats, Journal of Traditional and Complementary Medicine, 2017;8(3):377–386. DOI: 10.1016/j.jtcme.2017.06.003.
61. Phitak T, Pothacharoen P, Settakorn J, Poompimol W, Caterson B, Kongtawelert P, Chondroprotective and anti-inflammatory effects of sesamin, Phytochemistry, 2012; 80 :77–88. DOI: 10.1016/j.phytochem.2012.05.016
Published
Abstract Display: 0 
PDF Downloads: 0 PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Rooshi Fareed , Shaziya Begum , Mohd Anwar , Fatima Khan , Sadaf Nawaz
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.